Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis

BMC Cancer

Volumn 7, Issue , 2007, Pages

  Turashvili, Gulisa ^a   Bouchal, Jan ^a   Baumforth, Karl ^b   Wei, Wenbin ^b   Dziechciarkova, Marta ^a   Ehrmann, Jiri ^a   Klein, Jiri ^a   Fridman, Eduard ^c   Skarda, Jozef ^a   Srovnal, Josef ^a   Hajduch, Marian ^a   Murray, Paul ^b   Kolar, Zdenek ^a  

^a PALACKÝ UNIVERSITY   (Czech Republic)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ASPORIN; COLLAGEN TRIPLE HELIX REPEAT CONTAINING 1 PROTEIN; GENE PRODUCT; PROTEIN COL3AI; UNCLASSIFIED DRUG; ASPN PROTEIN, HUMAN; BIOLOGICAL MARKER; CADHERIN; COL3A1 PROTEIN, HUMAN; COLLAGEN TYPE 3; CTHRC1 PROTEIN, HUMAN; SCLEROPROTEIN;

ARTICLE; BREAST CARCINOMA; CANCER INVASION; CLINICAL ARTICLE; CONTROLLED STUDY; EPITHELIUM CELL; GENE AMPLIFICATION; GENE EXPRESSION PROFILING; GENE IDENTIFICATION; GENETIC ALGORITHM; GENETIC TRANSCRIPTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; IN VITRO STUDY; LASER MICRODISSECTION; MICROARRAY ANALYSIS; POLYMERASE CHAIN REACTION; POSTMENOPAUSE; PROGNOSIS; SAMPLING; TISSUE MICROARRAY; TUMOR DIFFERENTIATION; VALIDATION PROCESS; BREAST; BREAST TUMOR; FEMALE; GENETICS; LASER; LUNG CARCINOMA; METABOLISM; METHODOLOGY; MICRODISSECTION; PAGET NIPPLE DISEASE; PATHOLOGY;

BIOLOGICAL MARKERS; BREAST; BREAST NEOPLASMS; CADHERINS; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; COLLAGEN TYPE III; EXTRACELLULAR MATRIX PROTEINS; FEMALE; GENE EXPRESSION PROFILING; HUMANS; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; LASERS; MICRODISSECTION; TISSUE ARRAY ANALYSIS;

EID: 34247200133     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-7-55     Document Type: Article

References (86)

1. Rosen PP Rosen's breast pathology Lippincots-Raven Publishers 1997
2. Weidner N Cote R Suster S Weiss L Modern Surgical Pathology Elsevier Science 2003
3. Winchester DJ Chang HR Graves TA Menck HR Bland KI Winchester DP A comparative analysis of lobular and ductal carcinoma of the breast: presentation, treatment, and outcomes J Am Coll Surg 1998 186 416-422 10.1016/S1072-7515(98)00051-9 9544955
4. Silverstein MJ Lewinsky BS Waisman JR Gierson ED Colburn WJ Senofsky GM Gamagami P Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma? Cancer 1994 73 1673-1677 10.1002/ 1097-0142(19940315)73:6<1673::AID-CNCR2820730620>3.0.CO;2-B 8156495
5. Toikkanen S Pylkkanen L Joensuu H Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma Br J Cancer 1997 76 1234-40 9365176
6. Molland JG Donnellan M Janu NC Carmalt HL Kennedy CW Gillett DJ Infiltrating lobular carcinoma - a comparison of diagnosis, management and outcome with infiltrating duct carcinoma Breast 2004 13 389-396 10.1016/j.breast.2004.03.004 15454194
7. Newman LA Buzdar AU Singletary SE Kuerer HM Buchholz T Ames FC Ross MI Hunt KK A prospective trial of preoperative chemotherapy in resectable breast cancer: Predictors of breast-conservation therapy feasibility Ann Surg Oncol 2002 9 228-234 11923128
8. Mersin H Yildirim E Gulben K Berberoglu U Is invasive lobular carcinoma different from invasive ductal carcinoma? Eur J Surg Oncol 2003 29 390-395 10.1053/ejso.2002.1423 12711296
9. Arpino G Bardou VJ Clark GM Elledge RM Infiltrating lobular carcinoma of the breast: Tumor characteristics and clinical outcome Breast Cancer Res 2004 6 R149-156 400666 15084238 10.1186/bcr767
10. Perou CM Jeffrey SS van de Rijn M Rees CA Eisen MB Ross DT Pergamenschikov A Williams CF Zhu SX Lee JC Lashkari D Shalon D Brown PO Botstein D Distinctive gene expression patterns in human mammary epithelial cells and breast cancers Proc Natl Acad Sci USA 1999 96 9212-9217 17759 10430922 10.1073/pnas.96.16.9212
11. Schena M Shalon D Davis RW Brown PO Quantitative monitoring of gene expression patterns with a complementary DNA microarray Science 1995 270 467-470 10.1126/science.270.5235.467 7569999
12. Bertucci F Viens P Hingamp P Nasser V Houlgatte R Birnbaum D Breast cancer revisited using DNA array-based gene expression profiling Int J Cancer 2003 103 565-571 10.1002/ijc.10867 12494462
13. Tavassoli FA Scnitt SJ Pathology of the breast New York: Elsevier 1992
14. Zhu G Reynolds L Crnogorac-Jurcevic T Gillett CE Dublin EA Marshall JF Barnes D D'Arrigo C Van Trappen PO Lemoine NR Hart IR Combination of microdissection and microarray analysis to identify gene expression changes between differentially located tumor cells in breast cancer Oncogene 2003 22 3742-3748 10.1038/sj.onc.1206428 12802281
15. Schuetz CS Bonin M Clare SE Nieselt K Sotlar K Walter M Fehm T Solomayer E Riess O Wallwiener D Kurek R Neubauer HJ Progression-specific genes identified by expression profiling of matched ductal carcinomas in situ and invasive breast tumors, combining laser capture microdissection and oligonucleotide microarray analysis Cancer Res 2006 66 5278-5286 10.1158/ 0008-5472.CAN-05-4610 16707453
16. Yang F Foekens JA Yu J Sieuwerts AM Timmermans M Klijn JG Atkins D Wang Y Jiang Y Laser microdissection and microarray analysis of breast tumors reveal ER-alpha related genes and pathways Oncogene 2006 25 1413-1419 10.1038/sj.onc.1209165 16261164
17. Aoyagi K Tatsuta T Nishigaki M Akimoto S Tanabe C Omoto Y Hayashi S Sakamoto H Sakamoto M Yoshida T Terada M Sasaki H A faithful method for PCR-mediated global mRNA amplification and its integration into microarray analysis on laser-captured cells Biochem Biophys Res Commun 2003 300 915-920 10.1016/S0006-291X(02)02967-4 12559960
18. Luzzi V Mahadevappa M Raja R Warrington JA Watson MA Accurate and reproducible gene expression profiles from laser capture microdissection, transcript amplification, and high density oligonucleotide microarray analysis J Mol Diagn 2003 5 9-14 12552074
19. Klur S Toy K Williams MP Certa U Evaluation of procedures for amplification of small-size samples for hybridization on microarrays Genomics 2004 83 508-517 10.1016/j.ygeno.2003.09.005 14962677
20. Ji W Zhou W Gregg K Lindpaintner K Davis S Davis S A method for gene expression analysis by oligonucleotide arrays from minute biological materials Anal Biochem 2004 331 329-339 10.1016/j.ab.2004.03.039 15265739
21. Sorlie T Tibshirani R Parker J Hastie T Marron JS Nobel A Deng S Johnsen H Pesich R Geisler S Demeter J Perou CM Lonning PE Brown PO Borresen-Dale AL Botstein D Repeated observation of breast tumor subtypes in independent gene expression data sets Proc Natl Acad Sci USA 2003 100 8418-8423 166244 12829800 10.1073/pnas.0932692100
22. Bertucci F Houlgatte R Granjeaud S Nasser V Loriod B Beaudoing E Hingamp P Jacquemier J Viens P Birnbaum D Nguyen C Prognosis of breast cancer and gene expression profiling using DNA arrays Ann N Y Acad Sci 2002 975 217-231 12538167
23. Reinholz MM Iturria SJ Ingle JN Roche PC Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: Analysis by real-time quantitative PCR Breast Cancer Res Treat 2002 74 255-269 10.1023/A:1016339120506 12206515
24. Mackay A Jones C Dexter T Silva RL Bulmer K Jones A Simpson P Harris RA Jat PS Neville AM Reis LF Lakhani SR O'Hare MJ cDNA microarray analysis of genes associated with ERBB2 (HER2/neu) overexpression in human mammary luminal epithelial cells Oncogene 2003 22 2680-2688 10.1038/ sj.onc.1206349 12730682
25. Barsky SH Myoepithelial mRNA expression profiling reveals a common tumor-suppressor phenotype Exp Mol Pathol 2003 74 113-122 10.1016/ S0014-4800(03)00011-X 12710942
26. Pusztai L Sotiriou C Buchholz TA Meric F Symmans WF Esteva FJ Sahin A Liu ET Hortobagi GN Molecular profiles of invasive mucinous and ductal carcinomas of the breast: A molecular case study Cancer Genet Cytogenet 2003 141 148-153 10.1016/S0165-4608(02)00737-9 12606133
27. Dressman MA Baras A Malinowski R Alvis LB Kwon I Walz TM Polymeropoulos MH Gene expression profiling detects gene amplification and differentiates tumor types in breast cancer Cancer Res 2003 63 2194-2199 12727839
28. Nyante SJ Devries S Chen YY Hwang ES Array-based comparative genomic hybridization of ductal carcinoma in situ and synchronous invasive lobular cancer Hum Pathol 2004 35 759-763 10.1016/j.humpath.2003.11.009 15188144
29. Sotiriou C Neo SY McShane LM Korn EL Long PM Jazaeri A Martiat P Fox SB Harris AL Liu ET Breast cancer classification and prognosis based on gene expression profiles from a population-based study Proc Natl Acad Sci USA 2003 100 10393-10398 193572 12917485 10.1073/pnas.1732912100
30. Sorlie T Perou CM Tibshirani R Aas T Geisler S Johnsen H Hastie T Eisen MB van de Rijn M Jeffrey SS Thorsen T Quist H Matese JC Brown PO Botstein D Eystein Lonning P Borresen-Dale AL Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications Proc Natl Acad Sci USA 2001 98 10869-10874 58566 11553815 10.1073/pnas.191367098
31. van de Rijn M Perou CM Tibshirani R Haas P Kallioniemi O Kononen J Torhorst J Sauter G Zuber M Kochli OR Mross F Dieterich H Seitz R Ross D Botstein D Brown P Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome Am J Pathol 2002 161 1991-1996 12466114
32. van't Veer LJ Dai H van de Vijver MJ He YD Hart AA Bernards R Friend SH Expression profiling predicts outcome in breast cancer Breast Cancer Res 2003 5 57-58 154139 12559048 10.1186/bcr562
33. Hedenfalk I Duggan D Chen Y Radmacher M Bittner M Simon R Meltzer P Gusterson B Esteller M Kallioniemi OP Wilfond B Borg A Trent J Raffeld M Yakhini Z Ben-Dor A Dougherty E Kononen J Bubendorf L Fehrle W Pittaluga S Gruvberger S Loman N Johannsson O Olsson H Sauter G Gene-expression profiles in hereditary breast cancer N Engl J Med 2001 344 539-548 10.1056/NEJM200102223440801 11207349
34. Grigoriadis A Mackay A Reis-Filho JS Steele D Iseli C Stevenson BJ Jongeneel CV Valgeirsson H Fenwick K Iravani M Leao M Simpson AJ Strausberg RL Jat PS Ashworth A Neville AM O'hare MJ Establishment of the epithelial-specific transcriptome of normal and malignant human breast cells based on MPSS and array expression data Breast Cancer Res 2006 8 R56 10.1186/bcr1604 17014703 1779497
35. Huiping C Sigurgeirsdottir JR Jonasson JG Eiriksdottir G Johannsdottir JT Egilsson V Ingvarsson S Chromosome alterations and E-cadherin gene mutations in human lobular breast cancer Br J Cancer 1999 81 1103-1110 10.1038/sj.bjc.6690815 10584868
36. Asgeirsson KS Jonasson JG Tryggvadottir L Olafsdottir K Sigurgeirsdottir JR Ingvarsson S Ogmundsdottir HM Altered expression of E-cadherin in breast cancer. patterns, mechanisms and clinical significance Eur J Cancer 2000 36 1098-1106 10.1016/S0959-8049(00)00062-9 10854942
37. Sarrio D Perez-Mies B Hardisson D Moreno-Bueno G Suarez A Cano A Martin-Perez J Gamallo C Palacios J Cytoplasmic localization of p120ctn and E-cadherin loss characterize lobular breast carcinoma from preinvasive to metastatic lesions Oncogene 2004 23 3272-3283 10.1038/ sj.onc.1207439 15077190
38. Korkola JE DeVries S Fridlyand J Hwang ES Estep AL Chen YY Chew KL Dairkee SH Jensen RM Waldman FM Differentiation of lobular versus ductal breast carcinomas by expression microarray analysis Cancer Res 2003 63 7167-7175 14612510
39. Zhao H Langerod A Ji Y Nowels KW Nesland JM Tibshirani R Bukholm IK Karesen R Botstein D Borresen-Dale AL Jeffrey SS Different gene expression patterns in invasive lobular and ductal carcinomas of the breast Mol Biol Cell 2004 15 2523-2536 420079 15034139 10.1091/ mbc.E03-11-0786
40. Breitling R Armengaud P Amtmann A Herzyk P Rank products: A simple, yet powerful, new method to detect differentially regulated genes in replicated microarray experiments FEBS Lett 2004 573 83-92 10.1016/ j.febslet.2004.07.055 15327980
41. Irizarry RA Bolstad BM Collin F Cope LM Hobbs B Speed TP Summaries of Affymetrix GeneChip probe level data Nucleic Acids Res 2003 31 e15 150247 12582260 10.1093/nar/gng015
42. Affymetrix package of the Bioconductor http://www.bioconductor.org
43. DAVID: Database for Annotation, Visualization and Integrated Discovery http://david.abcc.ncifcrf.gov
44. Gene Cards http://www.genecards.org
45. NETAFFX Analysis Center http://www.affymetrix.com/analysis;
46. dChip software: Gene Expression Microarray and SNP Microarray Analysis http://www.dchip.org
47. NCBIs Gene Expression Omnibus http://www.ncbi.nlm.nih.gov/geo
48. Simon R Sauter G Tissue microarrays for miniaturized high-throughput molecular profiling of tumors Exp Hematol 2002 30 1365-1372 10.1016/ S0301-472X(02)00965-7 12482497
49. Henry SP Takanosu M Boyd TC Mayne PM Eberspaecher H Zhou W de Crombrugghe B Hook M Mayne R Expression pattern and gene characterization of asporin. a newly discovered member of the leucine-rich repeat protein family J Biol Chem 2001 276 12212-12221 10.1074/jbc.M011290200 11152695
50. Nakamura S Terashima T Yoshida T Iseki S Takano Y Ishikawa I Shinomura T Identification of genes preferentially expressed in periodontal ligament: Specific expression of a novel secreted protein, FDC-SP Biochem Biophys Res Commun 2005 338 1197-1203 10.1016/j.bbrc.2005.10.076 16259954
51. Gusterson BA Ross DT Heath VJ Stein T Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer Breast Cancer Res 2005 7 143-8 1175069 15987465 10.1186/ bcr1041
52. Peinado H Portillo F Cano A Transcriptional regulation of cadherins during development and carcinogenesis Int J Dev Biol 2004 48 365-375 10.1387/ijdb.041794hp 15349812
53. Grille SJ Bellacosa A Upson J Klein-Szanto AJ van Roy F Lee-Kwon W Donowitz M Tsichlis PN Larue L The protein kinase Akt induces epithelial mesenchymal transition and promotes enhanced motility and invasiveness of squamous cell carcinoma lines Cancer Res 2003 63 2172-2178 12727836
54. Thiery JP Epithelial-mesenchymal transitions in development and pathologies Curr Opin Cell Biol 2003 15 740-746 10.1016/ j.ceb.2003.10.006 14644200
55. Thiery JP Epithelial-mesenchymal transitions in tumour progression Nat Rev Cancer 2002 2 442-454 10.1038/nrc822 12189386
56. Kalluri R Neilson EG Epithelial-mesenchymal transition and its implications for fibrosis J Clin Invest 2003 112 1776-1784 297008 14679171 10.1172/JCI200320530
57. Nishidate T Katagiri T Lin ML Mano Y Miki Y Kasumi F Yoshimoto M Tsunoda T Hirata K Nakamura Y Genome-wide gene-expression profiles of breast-cancer cells purified with laser microbeam microdissection: identification of genes associated with progression and metastasis Int J Oncol 2004 25 797-819 15375528
58. Cheng JQ Lindsley CW Cheng GZ Yang H Nicosia SV The Akt/PKB pathway: molecular target for cancer drug discovery Oncogene 2005 24 7482-7492 10.1038/sj.onc.1209088 16288295
59. Schambony A Kunz M Gradl D Cross-regulation of Wnt signaling and cell adhesion Differentiation 2004 72 307-318 10.1111/ j.1432-0436.2004.07207002.x 15554942
60. Esko JD Rostand KS Weinke JL Tumor formation dependent on proteoglycan biosynthesis Science 1988 241 1092-1096 10.1126/science.3137658 3137658
61. Kizawa H Kou I Iida A Sudo A Miyamoto Y Fukuda A Mabuchi A Kotani A Kawakami A Yamamoto S Uchida A Nakamura K Notoya K Nakamura Y Ikegawa S An aspartic acid repeat polymorphism in asporin inhibits chondrogenesis and increases susceptibility to osteoarthritis Nat Genet 2005 37 138-144 10.1038/ng1496 15640800
62. Loughlin J Polymorphism in signal transduction is a major route through which osteoarthritis susceptibility is acting Curr Opin Rheumatol 2005 17 629-633 10.1097/01.bor.0000176687.85198.49 16093844
63. Best CJ Gillespie JW Yi Y Chandramouli GV Perlmutter MA Gathright Y Erickson HS Georgevich L Tangrea MA Duray PH Gonzalez S Velasco A Linehan WM Matusik RJ Price DK Figg WD Emmert-Buck MR Chuaqui RF Molecular alterations in primary prostate cancer after androgen ablation therapy Clin Cancer Res 2005 11 6823-6834 1432092 16203770 10.1158/ 1078-0432.CCR-05-0585
64. Tang L Dai DL Su M Martinka M Li G Zhou Y Aberrant expression of collagen triple helix repeat containing 1 in human solid cancers Clin Cancer Res 2006 12 3716-3722 10.1158/1078-0432.CCR-06-0030 16778098
65. Pyagay P Heroult M Wang Q Lehnert W Belden J Liaw L Friesel RE Lindner V Collagen triple helix repeat containing 1, a novel secreted protein in injured and diseased arteries, inhibits collagen expression and promotes cell migration Circ Res 2005 96 261-268 10.1161/ 01.RES.0000154262.07264.12 15618538
66. Zhao X Ramsey KE Stephan DA Russell P Gene and protein expression changes in human trabecular meshwork cells treated with transforming growth factor-beta Invest Ophthalmol Vis Sci 2004 45 4023-4034 10.1167/ iovs.04-0535 15505052
67. Durmus T Leclair RJ Park KS Terzic A Yoon JK Lindner V Expression analysis of the novel gene collagen triple helix repeat containing-1 (Cthrc1) Gene Expr Patterns 2006 6 935-940 10.1016/j.modgep.2006.03.008 16678498
68. Klopocki E Kristiansen G Wild PJ Klaman I Castanos-Velez E Singer G Stohr R Simon R Sauter G Leibiger H Essers L Weber B Hermann K Rosenthal A Hartmann A Dahl E Loss of SFRP1 is associated with breast cancer progression and poor prognosis in early stage tumors Int J Oncol 2004 25 641-649 15289865
69. Eger A Stockinger A Park J Langkopf E Mikula M Gotzmann J Mikulits W Beug H Foisner R beta-Catenin and TGFbeta signalling cooperate to maintain a mesenchymal phenotype after FosER-induced epithelial to mesenchymal transition Oncogene 2004 23 2672-2680 10.1038/sj.onc.1207416 14755243
70. Huber MA Azoitei N Baumann B Grunert S Sommer A Pehamberger H Kraut N Beug H Wirth T NF-kappaB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression J Clin Invest 2004 114 569-581 503772 15314694 10.1172/JCI200421358
71. Willert K Brown JD Danenberg E Duncan AW Weissman IL Reya T Yates JR 3rd Nusse R Wnt proteins are lipidmodified and can act as stem cell growth factors Nature 2003 423 448-452 10.1038/nature01611 12717451
72. Papkoff J Rubinfeld B Schryver B Polakis P Wnt-1 regulates free pools of catenins and stabilizes APC-catenin complexes Mol Cell Biol 1996 16 2128-2134 231200 8628279
73. Veeman MT Axelrod JD Moon RT A second canon: Functions and mechanisms of beta-catenin-independent wnt signaling Dev Cell 2003 5 367-377 10.1016/ S1534-5807(03)00266-1 12967557
74. Gradl D Kuhl M Wedlich D The Wnt/Wg signal transducer beta-catenin controls fibronectin expression Mol Cell Biol 1999 19 5576-5587 84410 10409747
75. Marchenko GN Marchenko ND Leng J Strongin AY Promoter characterization of the novel human matrix metalloproteinase-26 gene: Regulation by the T-cell factor-4 implies specific expression of the gene in cancer cells of epithelial origin Biochem J 2002 363 253-262 1222473 11931652 10.1042/ 0264-6021:3630253
76. Brabletz T Jung A Dag S Hlubek F Kirchner T Beta-catenin regulates the expression of the matrix metalloproteinase-7 in human colorectal cancer Am J Pathol 1999 155 1033-1038 10514384
77. Crawford HC Fingleton BM Rudolph-Owen LA Goss KJ Rubinfeld B Polakis P Matrisian LM The metalloproteinase matrilysin is a target of beta-catenin transactivation in intestinal tumors Oncogene 1999 18 2883-2891 10.1038/sj.onc.1202627 10362259
78. Rivat C Le Floch N Sabbah M Teyrol I Redeuilh G Bruyneel E Mareel M Matrisian LM Crawford HC Gespach C Attoub S Synergistic cooperation between the AP-1 and LEF-1 transcription factors in activation of the matrilysin promoter by the src oncogene: Implications in cellular invasion FASEB J 2003 17 1721-1723 12958188
79. Schlessinger J Plotnikov AN Ibrahimi OA Eliseenkova AV Yeh BK Yayon A Linhardt RJ Mohammadi M Crystal structure of a ternary FGF-FGFR-heparin complex reveals a dual role for heparin in FGFR binding and dimerization Mol Cell 2000 6 743-750 10.1016/S1097-2765(00)00073-3 11030354
80. Ai X Do AT Lozynska O Kusche-Gullberg M Lindahl U Emerson CP Jr QSulf1 remodels the 6-O sulfation states of cell surface heparan sulfate proteoglycans to promote Wnt signaling J Cell Biol 2003 162 341-351 10.1083/jcb.200212083 12860968
81. Chong JM Uren A Rubin JS Speicher DW Disulfide bond assignments of secreted Frizzled-related protein-1 provide insights about Frizzled homology and netrin modules J Biol Chem 2002 277 5134-5144 10.1074/ jbc.M108533200 11741940
82. Weeraratna AT Jiang YA Hostetter G Rosenblatt K Duray P Bittner M Trent JM Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma Cancer Cell 2002 1 279-288 10.1016/ S1535-6108(02)00045-4 12086864
83. Jonsson M Dejmek J Bendahl PO Andersson T Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas Cancer Res 2002 62 409-416 11809689
84. Chen Y Medvedev A Ruzanov P Marvin KW Jetten AM cDNA cloning, genomic structure, and chromosome mapping of the human epithelial membrane protein CL-20 gene (EMP1), a member of the PMP22 family Genomics 1997 41 40-48 10.1006/geno.1997.4524 9126480
85. Dejmek J Dib K Jonsson M Andersson T Wnt-5a and G-protein signaling are required for collagen-induced DDR1 receptor activation and normal mammary cell adhesion Int J Cancer 2003 103 344-351 10.1002/ijc.10752 12471617
86. Jonsson M Andersson T Repression of Wnt-5a impairs DDR1 phosphorylation and modifies adhesion and migration of mammary cells J Cell Sci 2001 114 2043-2053 11493640